Making Effective HPV Vaccine Recommendations
Two attendance options:
If you are interested in attending the evening educational event with Dr. Brewer on Wednesday, April 4 beginning at 6 pm, please register here.
DMU faculty, staff, students, residents, and the medical community.
Nearly all cases of cervical cancer are caused by infection with high-risk types of human papilloma virus (HPV). The virus also has been linked to cancers of the vagina, vulva, anus, penis, and throat. HPV vaccination prevents infection by virus types that cause the vast majority of these cancers and genital warts, but the vaccine works only if given well before an infection occurs.
Vaccination at these younger ages also leads to a greater immune response. Despite the power of HPV vaccination to prevent cervical cancer, only one-third of adolescent girls have completed the 3-dose series. The CDC reports that vaccination coverage increased slightly between 2012 and 2013 with another slight increase between 2013 and 2014, the President’s Cancer Panel released a report calling “underuse of HPV vaccines a serious but correctable threat to progress against cancer.”
- Learn the latest on HPV vaccine research and guidelines.
- Utilize evidence-based communication strategies to increase vaccine uptake by your adolescent patients.
- Listen to stories of Iowans who have been through treatment for HPV associated cancers.
- List six HPV associated cancers.
- American Cancer Society National HPV Vaccination Roundtable
- American Cancer Society HPV
- Advice For Doctors Talking To Parents About HPV Vaccine: Make It Brief
- Good Talks Needed to Combat HPV Vaccine Myth
Noel Brewer, PhD
Professor, Department of Health Behavior, UNC Gillings School of Global Public Health
Adjunct Professor, Department of Psychology, UNC Gillings School of Global Public Health
Chair, National HPV Vaccination Roundtable, American Cancer Society
Dr. Brewer studies how people make risky health decisions. His current work focuses on increasing HPV vaccination, communicating the harms of smoking, and encouraging appropriate use of screening. He is a professor in the Department of Health Behavior.
Relevant to the content of this CME activity, Dr. Brewer indicated he receives grant funding from Merck, GSK, and Pfizer and is a paid advisory board member for Merck.
Des Moines University is located on a 22-acre campus in the heart of Des Moines, Iowa. Just west of downtown on Grand Avenue, the University is located in one of Des Moines’ most prestigious neighborhoods. The campus is in a historic neighborhood filled with tree-lined streets and gracious older homes and businesses. Its central location makes it easy to access the rest of the city and outlying communities. The campus is close to the Des Moines International Airport, located on the bus line and just blocks from local shopping and downtown Des Moines.
Continuing Education Credit
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this live activity for 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University continuing education is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit awarded.
- Other healthcare providers: This live activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.
This training developed with funding from Pfizer and the Centers for Disease Control and Prevention.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.00 AOA Category 2A
- 1.00 AMA PRA Category 1 Credits™
- 1.00 IBON
- 1.00 CE Contact Hour(s)